|
WO1998014212A1
(en)
|
1996-09-30 |
1998-04-09 |
Embrex, Inc. |
Method of producing active immunity with vaccine conjugate
|
|
DE69836428T2
(de)
*
|
1997-08-21 |
2007-09-27 |
Takara Bio Inc., Otsu |
Karzinostatische wirkstoffe
|
|
EP1054683B1
(en)
*
|
1998-02-20 |
2007-04-11 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
ES2328194T3
(es)
*
|
1998-05-26 |
2009-11-10 |
Genitrix Llc |
Composiciones y procedimientos de modulacion de una respuesta inmunitaria frente a un antigeno mediante la administracion de celulas recubiertas con citocina.
|
|
US7030211B1
(en)
*
|
1998-07-08 |
2006-04-18 |
Gemvax As |
Antigenic peptides derived from telomerase
|
|
US6884785B2
(en)
*
|
1999-06-17 |
2005-04-26 |
The Scripps Research Institute |
Compositions and methods for the treatment or prevention of autoimmune diabetes
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US8128922B2
(en)
*
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
GB9930591D0
(en)
*
|
1999-12-23 |
2000-02-16 |
Univ London |
Component for vaccine
|
|
EP1363938B1
(en)
*
|
2000-08-03 |
2013-12-11 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
CN1487839A
(zh)
*
|
2000-11-27 |
2004-04-07 |
ղ˹��C��ղ˹���˹ |
用作佐剂的集合素
|
|
US7507724B2
(en)
|
2001-01-16 |
2009-03-24 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
|
WO2003035683A2
(en)
*
|
2001-10-26 |
2003-05-01 |
Uffe Holmskov |
Surfactant protein-d and atherosclerosis
|
|
WO2004006837A2
(en)
*
|
2002-07-12 |
2004-01-22 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20090110702A1
(en)
*
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
AU2003262650B2
(en)
|
2002-08-14 |
2009-10-29 |
Macrogenics, Inc. |
FcgammaRIIB-specific antibodies and methods of use thereof
|
|
MXPA05001953A
(es)
*
|
2002-08-20 |
2005-06-22 |
Genitrix Llc |
Composiciones de lecitina y metodos para modular una respuesta inmune a un antigeno.
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
AU2004224425B2
(en)
*
|
2003-02-06 |
2010-06-24 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
US7695725B2
(en)
*
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
PT1592441E
(pt)
*
|
2003-02-06 |
2012-05-21 |
Aduro Biotech |
Listeria atenuada relativamente à entrada em células não patogénicas, vacinas compreendendo a listeria e métodos para sua utilização
|
|
US9701725B2
(en)
*
|
2003-05-05 |
2017-07-11 |
The Johns Hopkins University |
Anti-cancer DNA vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
GB0315991D0
(en)
*
|
2003-07-08 |
2003-08-13 |
Dakocytomation Denmark As |
Standard
|
|
US7842289B2
(en)
*
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
CA2594040A1
(en)
*
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
JP2008528004A
(ja)
*
|
2005-01-26 |
2008-07-31 |
ザ ジョンズ ホプキンス ユニバーシティー |
突然変異癌タンパク質抗原およびカルレティキュリンをコードするプラスミドを用いる抗癌ｄｎａワクチン
|
|
US20060188526A1
(en)
*
|
2005-02-24 |
2006-08-24 |
Cunnion Kenji M |
Method for enhancing the immune response to Staphylococcus aureus infection
|
|
EP3097924B1
(en)
|
2005-11-29 |
2020-01-08 |
Intrexon Actobiotics NV |
Induction of mucosal tolerance to gliadin
|
|
ATE534415T1
(de)
|
2005-12-13 |
2011-12-15 |
Harvard College |
Gerüste zur zelltransplantation
|
|
WO2007084661A2
(en)
*
|
2006-01-17 |
2007-07-26 |
Sloan-Kettering Institute For Cancer Research |
Therapy-enhancing glucan
|
|
CA2651962A1
(en)
*
|
2006-05-12 |
2007-12-21 |
Oklahoma Medical Research Foundation |
Anthrax compositions and methods of use and production
|
|
SI2029173T1
(sl)
|
2006-06-26 |
2016-12-30 |
Macrogenics, Inc. |
Protitelesa, specifična za Fc RIIB, in postopki za njihovo uporabo
|
|
WO2008024844A2
(en)
*
|
2006-08-22 |
2008-02-28 |
The Johns Hopkins University |
Anticancer combination therapies
|
|
CA3037889C
(en)
|
2007-01-25 |
2022-09-13 |
Intrexon Actobiotics Nv |
Treatment of immune disease by mucosal delivery of antigens
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080260765A1
(en)
*
|
2007-03-15 |
2008-10-23 |
Johns Hopkins University |
HPV DNA Vaccines and Methods of Use Thereof
|
|
WO2009039125A1
(en)
*
|
2007-09-17 |
2009-03-26 |
The Schepens Eye Research Institute, Inc. |
Use of ocular neuropeptides as immune adjuvants
|
|
AU2009215188B2
(en)
|
2008-02-13 |
2014-09-18 |
Dana-Farber Cancer Institute, Inc. |
Continuous cell programming devices
|
|
JP2011513399A
(ja)
|
2008-03-03 |
2011-04-28 |
ザ ユニバーシティー オブ マイアミ |
同種癌細胞による免疫療法
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
US20090285861A1
(en)
*
|
2008-04-17 |
2009-11-19 |
Tzyy-Choou Wu |
Tumor cell-based cancer immunotherapeutic compositions and methods
|
|
JP5959440B2
(ja)
|
2010-01-19 |
2016-08-02 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
病原体の検出および治療のための改変オプソニン
|
|
SI2624873T1
(sl)
|
2010-10-06 |
2020-07-31 |
President And Fellows Of Harvard College |
Injektabilni, pore-formirajoči hidrogeli za celične terapije - na osnovi materialov
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
EP2734843A2
(en)
|
2011-07-18 |
2014-05-28 |
President and Fellows of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
|
EP2768942B1
(en)
|
2011-10-17 |
2019-12-04 |
Massachusetts Institute of Technology |
Intracellular delivery
|
|
WO2013130875A1
(en)
|
2012-02-29 |
2013-09-06 |
President And Fellows Of Harvard College |
Rapid antibiotic susceptibility testing
|
|
EP3662896B1
(en)
|
2012-04-16 |
2024-02-28 |
President and Fellows of Harvard College |
Mesoporous silica compositions for modulating immune responses
|
|
EP2674167A1
(en)
*
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
|
WO2014144325A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Methods and compositions for improving detection and/or capture of a target entity
|
|
EP3010522B1
(en)
|
2013-05-21 |
2021-01-20 |
President and Fellows of Harvard College |
Engineered heme-binding compositions and uses thereof
|
|
AU2014306423B2
(en)
|
2013-08-16 |
2019-04-18 |
Massachusetts Institute Of Technology |
Selective delivery of material to cells
|
|
EP3912986B1
(en)
|
2013-12-18 |
2023-12-13 |
President and Fellows of Harvard College |
Crp capture/detection of bacteria
|
|
JP7348708B2
(ja)
|
2014-04-30 |
2023-09-21 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
組み合わせワクチン装置および癌細胞を殺滅する方法
|
|
EP3212772A4
(en)
|
2014-10-31 |
2018-10-03 |
Massachusetts Institute of Technology |
Delivery of biomolecules to immune cells
|
|
CA2964138C
(en)
|
2014-11-14 |
2023-11-14 |
Massachusetts Institute Of Technology |
Disruption and field enabled delivery of compounds and compositions into cells
|
|
JP7278027B2
(ja)
|
2015-01-12 |
2023-05-19 |
マサチューセッツ インスティテュート オブ テクノロジー |
マイクロ流体送達による遺伝子編集
|
|
WO2016123573A1
(en)
|
2015-01-30 |
2016-08-04 |
President And Fellows Of Harvard College |
Peritumoral and intratumoral materials for cancer therapy
|
|
JP6744318B2
(ja)
|
2015-02-06 |
2020-08-26 |
ヒート バイオロジクス，インコーポレイテッド |
ワクチンおよび共刺激分子を共発現するベクター
|
|
WO2016164705A1
(en)
|
2015-04-10 |
2016-10-13 |
Omar Abdel-Rahman Ali |
Immune cell trapping devices and methods for making and using the same
|
|
CA2988996A1
(en)
|
2015-07-09 |
2017-01-12 |
Massachusetts Institute Of Technology |
Delivery of materials to anucleate cells
|
|
EP3331549B1
(en)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Improved microbe-binding molecules and uses thereof
|
|
WO2017041051A1
(en)
|
2015-09-04 |
2017-03-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to cells comprising a cell wall
|
|
EP3411475B1
(en)
|
2016-02-06 |
2025-08-27 |
President and Fellows of Harvard College |
Recapitulating the hematopoietic niche to reconstitute immunity
|
|
CN108697778B
(zh)
|
2016-02-16 |
2023-10-03 |
哈佛学院院长等 |
病原体疫苗及其生产和使用方法
|
|
CN109789092A
(zh)
|
2016-07-13 |
2019-05-21 |
哈佛学院院长等 |
抗原呈递细胞模拟支架及其制备和使用方法
|
|
CA3032505A1
(en)
|
2016-08-02 |
2018-02-08 |
President And Fellows Of Harvard College |
Biomaterials for modulating immune responses
|
|
WO2018071405A1
(en)
|
2016-10-11 |
2018-04-19 |
University Of Miami |
Vectors and vaccine cells for immunity against zika virus
|
|
WO2018187260A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
JP2020533414A
(ja)
|
2017-09-11 |
2020-11-19 |
インサイドアウトバイオ インコーポレイテッド |
腫瘍の免疫原性を増強する方法および組成物
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
US20210403519A1
(en)
|
2018-11-02 |
2021-12-30 |
Insideoutbio, Inc. |
Methods and compositions to induce or suppress immune responses through the use of membrane bound complement split products
|
|
JP2022549270A
(ja)
|
2019-09-23 |
2022-11-24 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
バイオマテリアルベースの無抗原ワクチンおよびその使用
|